Ritonavir-Boosted Darunavir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Other Regimens for Initial Antiretroviral Therapy for People with HIV Infection: A Systematic Review

Documenti analoghi

• Dolutegravir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Efavirenz Plus Two Nucleoside Reverse Transcriptase Inhibitors As Initial Antiretroviral Therapy for People with HIV: A Systematic Review.
  di: George W Rutherford, et al.
  Pubblicazione: (2016-01-01)
• Dolutegravir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Efavirenz Plus Two Nucleoside Reverse Transcriptase Inhibitors As Initial Antiretroviral Therapy for People with HIV: A Systematic Review
  di: Rutherford, George W., et al.
  Pubblicazione: (2016)
• Lamivudine plus darunavir boosted with ritonavir as simplification dual regimen in HIV-infected patients
  di: Luis Casado, Jose, et al.
  Pubblicazione: (2014)
• Management of Antiretroviral Therapy with Boosted Protease Inhibitors—Darunavir/Ritonavir or Darunavir/Cobicistat
  di: Marin, Ruxandra-Cristina, et al.
  Pubblicazione: (2021)
• The choice between a ritonavir-boosted protease inhibitor- and a non-nucleoside reverse transcriptase inhibitor-based regimen for initiation of antiretroviral treatment – results from an observational study in Germany
  di: Mahlich, Jörg, et al.
  Pubblicazione: (2016)